Subtype
Pancreatic Carcinoma
CI-CAN-00003562Explore in graph →
489 active trials5 approved drugs31 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003562Explore in graph →
Clinical trials
1,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (201)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05604716 | Cross-sectional Follow-up on Digestive and Social Functions of SPN | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT05580887 | Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients | unknown | — | 35 | Moscow Clinical Scientific CenterOTHER | 1 | Oct 14, 2022 |
| clinicaltrials |
| NCT05571956 | Establishment of Pancreas Cancer and Cancer-associated Fibroblast Using EUS-guided Biopsy Samples | unknown | N/A | 50 | Ajou University School of MedicineOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT05181605 | Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors | unknown | Phase 2 / Phase 3 | 116 | Instituto de investigación e innovación biomédica de CádizOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05493878 | ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer | unknown | — | 128 | Assiut UniversityOTHER | 0 | Aug 9, 2022 | clinicaltrials |
| NCT04258072 | Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. | unknown | Phase 1 | 24 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05400681 | Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer(LIPAC) | unknown | — | 200 | Sonke DetlefsenOTHER | 1 | Jun 8, 2022 | clinicaltrials |
| NCT02839343 | Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | 126 | Alliance for Clinical Trials in OncologyOTHER | 2 | May 24, 2022 | clinicaltrials |
| NCT05253313 | Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial(MAGIPAC) | unknown | N/A | 200 | University of AarhusOTHER | 0 | Mar 16, 2022 | clinicaltrials |
| NCT05275985 | 68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma | unknown | N/A | 80 | Peking Union Medical College HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT04835402 | Electroporation Potentiated Immunotherapy in Cancer(EPIC-1) | unknown | Phase 2 | 8 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT04812808 | Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma(BAZE) | unknown | N/A | 10 | Hôpital FribourgeoisOTHER | 1 | Feb 25, 2022 | clinicaltrials |
| NCT05257122 | A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer | unknown | Phase 2 | 32 | Fudan UniversityOTHER | 1 | Feb 25, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT05201729 | Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer | unknown | — | 30 | Ruijin HospitalOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT04617821 | AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer | unknown | Phase 3 | 300 | Fudan UniversityOTHER | 1 | Jan 28, 2022 | clinicaltrials |
| NCT05192044 | Less Than 100 Hours Hospital Stay After Pancreatico-duodenectomy, RCT | unknown | N/A | 40 | National Cancer Institute, EgyptOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT03978702 | Evaluation of the Impact of Pancreatectomy on Systemic Immunity(IMMUNOPANC) | unknown | N/A | 40 | Institut Paoli-CalmettesOTHER | 1 | Jan 6, 2022 | clinicaltrials |
| NCT04652206 | Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.(PANTAX-Ib) | unknown | Phase 1 / Phase 2 | 18 | Scandion Oncology A/SINDUSTRY | 2 | Dec 29, 2021 | clinicaltrials |
| NCT05168254 | Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer | unknown | — | 50 | Ruijin HospitalOTHER | 1 | Dec 23, 2021 | clinicaltrials |
| NCT02944006 | Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling | unknown | — | 29 | Seoul National University HospitalOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT05143151 | CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer(CAR-T) | unknown | Phase 1 / Phase 2 | 10 | Shenzhen University General HospitalOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT05066802 | A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma | unknown | Phase 2 | 27 | Yonsei UniversityOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT04718701 | Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer(ATNPA) | unknown | Phase 2 | 53 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 16, 2021 | clinicaltrials |
| NCT03528785 | A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer(nITRo) | unknown | Phase 2 | 67 | Centro Ricerche Cliniche di VeronaOTHER | 1 | Aug 2, 2021 | clinicaltrials |
| NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer(PROTACT) | unknown | Phase 2 | 80 | Silenseed LtdINDUSTRY | 2 | Jul 2, 2021 | clinicaltrials |
| NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer(TIMEPAN) | unknown | Phase 3 | 184 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT04892927 | NCI SBIR Contract for Patient Navigation Tool Prototype Development | unknown | — | 25 | GMG Arcdata LLCINDUSTRY | 1 | May 19, 2021 | clinicaltrials |
| NCT03865875 | Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program | unknown | N/A | 40 | Massachusetts General HospitalOTHER | 1 | May 17, 2021 | clinicaltrials |
| NCT04211948 | Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer | unknown | N/A | 300 | Ruijin HospitalOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04835064 | Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. | unknown | Phase 3 | 600 | Fudan UniversityOTHER | 0 | Apr 8, 2021 | clinicaltrials |
| NCT04814251 | Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study(THROMPAN) | unknown | — | 200 | Poitiers University HospitalOTHER | 0 | Mar 24, 2021 | clinicaltrials |
| NCT03140592 | Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue | unknown | — | 300 | Stony Brook UniversityOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT04739046 | An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | unknown | Phase 2 | 12 | Seoul National University Bundang HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04794140 | A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC | unknown | N/A | 60 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT04777604 | Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid | unknown | — | 300 | Samsung Medical CenterOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04524260 | The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients | unknown | N/A | 80 | University of ZurichOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT03703063 | Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer | unknown | Phase 1 | 30 | Benaroya Research InstituteOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04687410 | Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs | unknown | N/A | 68 | Peter Vilmann MD, DSc, HC, FASGEOTHER | 1 | Dec 29, 2020 | clinicaltrials |
| NCT04636788 | Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer | unknown | N/A | 102 | Huazhong University of Science and TechnologyOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT01703650 | Role of Perfusion CT in Pancreatic Cancer | unknown | — | 48 | Seoul National University HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03138213 | Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy | unknown | N/A | 656 | Tongji HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04167007 | FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX(GEMFOX) | unknown | Phase 3 | 400 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04517019 | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy(OnkoFit II) | unknown | N/A | 201 | University Hospital TuebingenOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT03507998 | Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors | unknown | Phase 1 | 39 | Curegenix Inc.INDUSTRY | 1 | Jul 24, 2020 | clinicaltrials |
| NCT04216758 | Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jun 30, 2020 | clinicaltrials |
| NCT02599662 | Intraoperative Radiation Therapy for Resectable Pancreas Cancer(IORT) | unknown | Phase 1 | 12 | Loyola UniversityOTHER | 1 | Jun 4, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Nov 3, 2022source: clinicaltrials